Defiance ETFs Umumkan Penggantungan Sementara Dagangan Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.
MIAMI, June 14, 2026 (GLOBE NEWSWIRE) — Defiance ETFs, peneraju dalam dana dagangan bursa bertema dan berleveraj, hari ini mengumumkan bahawa dagangan saham Defiance Daily 2X Space ETF (Cboe BZX: SPCL)
Salomon Unfolds the Next Chapter of ROAD TO THE FUTURE in Shanghai
SHANGHAI, June 14, 2026 (GLOBE NEWSWIRE) — French outdoor brand Salomon has officially unsealed the latest instalment of the ROAD TO THE FUTURE programme at the Anfu concept store in
Rally House Ready with New York Knicks Championship Gear Following NBA Finals Victory
NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) — The New York Knicks are NBA Champions, and Rally House is helping fans celebrate with officially licensed championship merchandise available starting tomorrow morning
ICE Box Claims Evaluated: Personal Document Storage System for Organization & Secure Protection in Case of Emergencies
Tinley Park, IL, June 13, 2026 (GLOBE NEWSWIRE) — Results may vary. ICE Box is not a substitute for legal, financial, insurance, estate-planning, or emergency-preparedness advice. See full terms through
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI
NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025
Nalvurikenz Officially Launches Its Advanced AI Trading Platform for the Next Generation of Intelligent Investing in 2026
New York City, June 13, 2026 (GLOBE NEWSWIRE) — In 2026, Nalvurikenz officially announced the release of its new AI-powered trading platform, integrating unique features and functionalities to simplify the
HeroMD 4-MAX Claims Evaluated: Why Men Searching “Most Effective 4-in-1 Erectile Dysfunction Formula” Are Comparing SURGE, PRIME and The HERO System Explained
Kennewick, WA, June 13, 2026 (GLOBE NEWSWIRE) — Compounded medications are not FDA-approved finished drug products. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before
EAACI Seru ke Arah Masa Depan “Vision Zero” Bebas daripada Beban Alahan dan Asma
ZURICH, June 13, 2026 (GLOBE NEWSWIRE) — Penyakit alahan terus menjejaskan ratusan juta orang di seluruh dunia dan menambah tekanan terhadap sistem kesihatan. Sehubungan itu, European Academy of Allergy and
EAACI Menyerukan Masa Depan “Vision Zero” yang Bebas dari Beban Alergi dan Asma
ZURICH, June 13, 2026 (GLOBE NEWSWIRE) — Penyakit alergi terus memengaruhi ratusan juta orang di seluruh dunia dan memberikan tekanan yang semakin besar pada sistem layanan kesehatan. Oleh karena itu,
KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026
RIYADH, Saudi Arabia, June 13, 2026 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH) will use its participation at HLTH Europe 2026, taking place from June 15
Penjelasan Rasmi dan Penafian oleh AIFA Berhubung Transaksi Pemerolehan Saham yang melibatkan HyalRoute Communication Group Limited
NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) — All In FutureTech Alliance Inc. (Nasdaq: AIFA) (“Syarikat” atau “AIFA”) baru-baru ini dimaklumkan bahawa pasukan pengurusan semasa HyalRoute Communication Group Limited (“HyalRoute”),
New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma
TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of up to 89.2% at 24 months1 MonumenTAL-3 is the third positive study in recent months
SPCL Menjadi ETF A.S. Pertama dan Satu-satunya Dengan Pendedahan 2X kepada SpaceX Pada Hari IPO
MIAMI, FL, June 13, 2026 (GLOBE NEWSWIRE) — Dengan SpaceX (NASDAQ: SPCX) dijangka mula didagangkan di Nasdaq hari ini, Defiance ETFs mengesahkan bahawa Defiance Daily 2X Space ETF (Cboe: SPCL)
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative
Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000
MONACO, June 12, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward AlphaPepe after the project unveiled AlphaSwap Early Access, giving users the ability to trade selected pairs across